Thirty eight patients with neurofibromatosis 1 (NFI) had neurological examinations, intellectual assessments and MRI scans. Increased intensity lesions on T2 weighted images were found in 13 patients. These abnormalities were more common in patients aged under 18 years. The lesions occurred predominantly in the basal ganglia, brainstem and cerebellum, and were multiple in 11 patients. They did not produce symptoms or neurological deficit in any patient and did not enhance with gadolinium-meglumine-triamine-pentacetic acid contrast medium (Gd-DTPA). In 2 patients, however, the abnormalities exerted mass effect distorting the brain and in 3 patients they occurred in conjunction with known gliomas.
Neurofibromatosis 1 is a common autosomal dominant disease with a minimum prevalence of 1 Table 1 Diagnostic features of neurofibromatosis 12 1 Cafe au lait spots 2 Two or more neurofibromas or one plexiform neurofibroma 3 Axillary or groin freckling 4 Lisch nodules 5 Optic nerve glioma 6 A first degree relative with NF 1 7 A distinctive osseous lesion such as sphenoid wing dysplasia or thinning of the long bone cortex with or without pseudarthrosis 2 or more criteria are required for diagnosis.
The cause of the intellectual difficulties has not been established. However, Rosman and Pearce5 showed in a post mortem study that patients with NF1 and intellectual impairment had heterotopias in the subcortical and deep white matter and disordered cerebral architecture. Patients with NFI and average intelligence had similar less severe changes but these abnormalities were absent in control subjects. They proposed that the intellectual problems were linked to migrational abnormalities in the brain of the developing fetus.
MRI is now the investigation of choice for visualising the distinction between grey and white matter in the brain. Increased intensity lesions have been detected on T2 weighted MRI brain scans in children and young adults with NFl. They occur predominantly in the basal ganglia, brainstem and cerebellum.67-9 They do not show mass effect and do not enhance with Gd-DTPA. The nature of the abnormalities is uncertain, but it has been suggested that they may be hamartomas or slow growing gliomas. The lesions are distinguishable from those in multiple sclerosis and vascular disease by their larger size and different location. Another possibility is that these lesions represent grey matter heterotopias. Mirowitz et al observed that 7 Total number of patients with abnormal scans = 28 normal scans = 10
Note: Some patients had more than one abnormality Four patients were mentally retarded with a full scale IQ range between 51 and 67. One of these subjects had a single increased intensity T2 weighted lesion in the region of the right insular cortex as described above.
Nineteen patients had an IQ in the range 70-89. Increased intensity lesions on T2 weighted images were seen in 8 of this group and were found predominantly in the basal ganglia, cerebellum and brainstem. Thirteen patients had an IQ range 91-112. Six had increased intensity T2 weighted lesions in the basal ganglia, cerebellum, cerebellar peduncle, and optic tract. There was therefore no significant association between the presence of T2 weighted lesions and intellectual impairment (p = 0 79).
Twenty five of 38 patients had macrocephaly defined as a head circumference greater than the 98th centile. Increased intensity T2 weighted lesions were present in 10 of these patients with macrocephaly and in 3 of the 13 with normal head circumferences. Among the 25 patients without T2 weighted abnormalities, 15 had macrocephaly and 10 had a normal head circumference. There was no statistically significant relationship between the presence of increased intensity lesions and macrocephaly.
Post mortem studies were carried out on 2 patients, a 59 year old male whose IQ had been 60 and a 61 year old female who had been a lawyer. In the first case a T2 weighted MRI scan had shown multiple high intensity lesions in the brainstem, basal ganglia and periventricular regions, which were considered to be infarcts, a diagnosis which was confirmed at post mortem. The MRI of the second patient showed multiple high signal lesions on T2 weighted images which were seen in the periventricular areas, pons and cerebellum. The lesions and clinical history were consistent with multiple sclerosis which was verified by the neuropathological examination. No evidence of heterotopias, gliomas or hamartomas was found in either patient.
Discussion
The most significant findings were high signal intensity lesions in the basal ganglia, brainstem and cerebellum on T2 weighted MRI scans in 8 of a selected population of 16 children with NF1, in agreement with previous studies.69 All the lesions in our series appeared to be asymptomatic. This fact, the lack of enhancement following Gd-DTPA, and the observation that similar lesions are less common in adults (only being present in 5 of 22 in our series) would suggest that the lesions are benign and might be hamartomatous. However, in 2 of our cases the lesions produced mass effect and in another 3 cases the lesions were associated with gliomas elsewhere in the brain which suggests that the lesions may have malignant potential. It is possible there are two different types of lesion, one which will regress and one which may develop into a glioma. Further follow up and rescanning of our patients should resolve this question. In the meantime we do not advocate that patients should be screened for the presence of these lesions as all of our patients have remained asymptomatic. Patients need to be scanned only in accordance with clinical indications. When these lesions are encountered in NF1, patients can be reassured that they are usually benign, but follow up is necessary. The nature of the high signal intensity lesions on T2 weighted MRI scans might be resolved by appropriate post mortem studies.
We also observed the usual range of abnormalities associated with NF1. The high frequency of optic nerve gliomas in this study can be attributed to the selection of cases by referral to our neurologically orientated Neurofibromatosis Clinic. However optic nerve gliomas are a recognised association with NF1 and were reported in 15% of 217 cases from a Neurofibromatosis Clinic with a more general orientation.'4 These optic nerve gliomas may be asymptomatic, as in 2 of our 6 cases, but may also cause visual failure and hydrocephalus. The three parenchymal gliomas in our series were located in the brainstem and thalamus: the possibility arises that they had originated in the optic tract and that the glial tissue of the anterior and posterior optic pathways has a particular potential for gliomatous change. Four patients had dilated ventricles and these were due to aqueduct stenosis, a tumour impinging on the foramen of Munro, cerebral atrophy and idiopathic ventriculomegaly. We detected occasional examples of other abnormalities with NF1 which have not been previously associated and may be coincidental (table 3) . Macrocephaly is recognised as a feature of NFP4 but it did not correlate with the presence of abnormalities found on T2 weighted MRI scans in our series, and it is not associated with intellectual impairment in NFl . 4 No differences were discovered between the MRI scans of those patients who were mentally retarded and those who were not, although patients with parenchymal gliomas showed the deterioration in cerebral function anticipated from the sites of their lesions. A post mortem study had shown that grey matter heterotopia was common in the brains of patients with NFl. 
